Agilent’s Cell-based Analytical Solutions for Process Development and Manufacturing of Immune Cell Therapies
Time: 10:00 am
day: Conference Day Two
Details:
- Overview and performance analysis of Agilent’s real-time, label-free cell analysis platforms for assessment of critical quality attributes of cell therapy products
- Discuss the advantages of metabolic fitness and immune cell killing functional assays during the evaluation of critical process parameters for manufacturing of engineered immune cells
- Explore using in-process monitoring of cell identity, potency and metabolic fitness to shorten cell therapy manufacturing process.
